Louisiana’s Subscription Model For Hep C Drugs Gains Traction

August 14, 2018
The Louisiana Department of Health took another step toward adopting a policy to pay an annual subscription fee over several years for hepatitis C drugs, and the National Governors Association included the subscription model among its list of strategies for states struggling with drug costs. Louisiana is the first state to publicly consider the subscription, and the National Governors Association says other stakeholders are interested in the concept. The subscription model, though in its early development, is getting cautious positive...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.